Daily News Watch

News Home Page

Access the 15 most recent news items below. For older items, please click the 'view archives' link in the lower right.

Agena Bioscience Introduces Front-End Automation for Its MassARRAY System for Genetic Analysis

Agena Bioscienc recently introduced the Chip prep module to automate sample handling after PCR for the MassARRAY 96-well System. This enables laboratories to operate the MassARRAY System largely unattended for high-throughput, multiplex genetic analysis."Automation of the post-PCR workflow reduces labor and helps to improve the quality and consistency of genetic testing. Laboratories can focus resources on the most impactful work," said Peter Dansky, Agena Bioscience's CEO. The Chip prep module ...

Posted on: September 03, 2015
Bio-Rad Mission: Control Risk Management Software Launched

Bio-Rad Laboratories, a global provider of life science research and clinical diagnostics products, announced the launch of Bio-Rad Mission: Control, the first objective risk management software to help laboratories identify the best QC rules and the right QC frequency to develop a customized quality control plan to deliver reliable test results.  Bio-Rad Mission: Control uniquely quantifies a laboratory's risk tolerance, going beyond traditional subjective risk assessments. Using Bio-Rad Mission: ...

Posted on: September 02, 2015
Roche Purchases Innovative Nucleic Acid Purification Technology from Lumora

Roche has signed a definitive asset purchase agreement with Lumora for products associated with the unique, patent-protected Heat Elution technology for nucleic acid purification of multiple sample types including challenging formalin-fixed paraffin-embedded (FFPE) tumor samples. Roche plans to explore integrating this technology into its sequencing workflow solution.Today, nucleic acid purification technology from specimens including formalin-fixed tissues can be cumbersome and inefficient. Lumora's ...

Posted on: September 01, 2015
Researchers Link Low Levels of Pro-Enkephalin to Future Breast Cancer in Healthy Women

Sphingotec announced that the results of two studies examining the association between proenkephalin (pro-ENK) and incident breast cancer were published online in The Journal of Clinical Oncology. The studies, which were conducted by researchers at Skåne University Hospital in Malmö, Sweden, and together encompass almost 3,500 subjects, demonstrated a strong association between low plasma concentration of the opioid precursor peptide pro-ENK and increased breast cancer risk in middle-aged and ...

Posted on: August 31, 2015
Markus Lusser Is New President of Leica Microsystems

Markus Lusser is the new president and director of Leica Microsystems, headquartered in Wetzlar, Germany. This appointment became effective July 1. He succeeds Andries Peter Jan van den Broek who has left the company.Before joining Leica Microsystems, Lusser was vice president global sales and customer support with Sciex. Sciex produces analysis instruments and, like Leica Microsystems, belongs to the U.S. company, Danaher Corporation. Lusser holds an electrical engineering degree in telecommunications ...

Posted on: August 30, 2015
Statistical Advances Help Unlock Mysteries of Human Microbiome

Advances in the field of statistics are helping to unlock the mysteries of the human microbiome-the vast collection of microorganisms living in and on the bodies of humans, said Katherine Pollard, a statistician and biome expert, during a session at the 2015 Joint Statistical Meetings (JSM 2015) in Seattle. Pollard, senior investigator at the Gladstone Institutes and professor of epidemiology and biostatistics at the University of California, San Francisco, delivered a presentation titled "Estimating ...

Posted on: August 28, 2015
Beckman Coulter Diagnostics and COPAN Expand Distribution Agreement

Beckman Coulter Diagnostics, a global leader in clinical diagnostics, and COPAN, a company committed to innovation in the field of pre-analytics, have agreed to expand their relationship into new products and geographic territories. Additional products include COPAN's WASPLab automated, front-end robotic specimen processing, full lab automation and digital microbiology system. The amendment grants Beckman Coulter distribution rights in 21 global markets, including a number of territories in North America, ...

Posted on: August 27, 2015
Epic Sciences' Detection of Circulating Tumor Cells from a Liquid Biopsy Validated in Publication

Epic Sciences announced the publication of its research in the Journal of Circulating Biomarkers validating the company's no cell left behindplatform. The data published demonstrate reproducible and linear assay performance in CTC enumeration as well as additional utility in downstream molecular characterization of single CTCs, including protein biomarker analysis and single cell genomics. The study goes on to illustrate clinical feasibility through direct application of the Epic Sciences platform to ...

Posted on: August 26, 2015
CRI Answers Labs' Top Questions about New Quality Control Plan

As laboratories continue their transition from EQC (Equivalent Quality Control) to IQCP (Individualized Quality Control Plan) in anticipation of CMS' Dec. 31 deadline, COLA Resources Inc. (CRI) is sharing answers to some of lab professionals' most frequently asked questions about the new quality control plan.Ranging from what is the purpose of IQCP to whether the new plan can save labs money, the list spans a wide variety of categories. A complete list of questions and answers are available as a ...

Posted on: August 25, 2015
bioMérieux receives FDA 510(k) clearance for VIDAS 3, the new generation of VIDAS

bioMérieux, a world leader in the field of in vitro diagnostics, has announced that VIDAS 3, the new generation of VIDAS, received FDA 510(k) clearance. This instrument, which further enriches the offering of the VIDAS immunoassay product range, VIDAS and mini VIDAS, is now commercially available in the United States. VIDAS 3 is CE marked and registered at the Chinese Food and Drug Administration (CFDA) which makes it available to clinical labs on a global scale. VIDAS 3 features enhanced automation, in ...

Posted on: August 24, 2015
Abbott to Offer New Informatics Capabilities to Labs Worldwide

Abbott has acquired Omnilab, a leading provider of software solutions for clinical diagnostics and blood transfusion laboratories.  Omnilab's software solutions, known as middleware, connect laboratory information systems (LIS) to analyzers, automation systems, point-of-care or other diagnostic devices within the laboratory. "With this acquisition, Abbott now has the ability to offer a seamless, all-in-one solution for customers," said Jaime Contreras, senior vice president, commercial ...

Posted on: August 23, 2015
UNIconnect's Precision MDx Goes Live For MedCompGx, Partners withTranslational Software to Integrate Multiple Systems

MedCompGx, a division of MedComp Sciences based in Memphis, Tenn., announced the installation and implementation of UNIConnect's Precision MDx (pMDxtm) laboratory information management system (LIMS) for its new genetic testing lab. The system is designed to provide comprehensive automation ofall laboratory processes, while integrating with multiple systems under one umbrella. The installation of pMDx will help to advance MedCompGx's mission to promote innovation in healthcare that creates better outcomes ...

Posted on: August 21, 2015
Nuclea Launches Panel of Ruo Biomarker Tests

Nuclea Biotechnologie shas begun offering more than 50 research use only (RUO) mass spectrometry-based biomarker tests as part of its laboratory services. Nuclea highlighted its new service offering available in addition to its CLIA/CAP certified labs at the American Association of Clinical Chemistry (AACC)'s annual conferenceMass spectrometry-based tests offer enhanced sensitivity, selectivity, reliability, precision and quantification when compared to traditional tests. The RUO tests are specifically ...

Posted on: August 20, 2015
Ortho Clinical Diagnostics Receives 510(k) Clearance for ORTHO VISION Analyzer

Ortho Clinical Diagnostics has obtained 510(k) clearance for the ORTHO VISION Analyzer, a highly interactive, fully automated analyzer for transfusion medicine laboratories. The ORTHO VISION Analyzer for Ortho ID-MTS Column Agglutination Technology is now commercially available in the United States and Puerto Rico. Although transfusion medicine has evolved to enhance safety and establish critical efficiencies, today's automation solutions lack the ability to anticipate and respond to ...

Posted on: August 19, 2015
Roche Submits Filing to FDA for Companion Diagnostic for Non-Small Cell Lung Cancer Drug Therapy

Roche has submitted the cobas EGFR Mutation Test v2 for Premarket Approval (PMA) to the FDA, as a companion diagnostic test for AZD9291, an AstraZeneca investigational therapy for non-small cell lung cancer patients with an acquired resistant mutation.Patients with non-small cell lung cancer who have adenocarcinoma with tumor containing an EGFR sensitizing mutation show significant benefit from currently available EGFR TKI therapies. However, approximately two-thirds of these patients will relapse and ...

Posted on: August 18, 2015
View Archives

Back to Top

© 2015 Merion Matters

2900 Horizon Drive, King of Prussia PA 19406